Protalix BioTherapeutics Market Cap

Protalix BioTherapeutics has a market cap or net worth of $180.48 million as of June 25, 2026. Its market cap has increased by 43.47% in one year.

Market Cap

180.48M

Enterprise Value

137.88M

1-Year Change

43.47%

Ranking

#3972

Market Cap Chart

Since December 1, 1998, Protalix BioTherapeutics's market cap has increased from $11.80M to $180.48M, an increase of 1,429.50%. That is a compound annual growth rate of 10.39%.

Market Cap History

Date	Market Cap	% Change
Jun 25, 2026	180.48M	24.64%
Dec 31, 2025	144.80M	4.62%
Dec 31, 2024	138.40M	6.54%
Dec 29, 2023	129.90M	87.18%
Dec 30, 2022	69.40M	83.11%
Dec 31, 2021	37.90M	-68.68%
Dec 31, 2020	121.00M	148.46%
Dec 31, 2019	48.70M	5.64%
Dec 31, 2018	46.10M	-50.11%
Dec 29, 2017	92.40M	107.64%
Dec 30, 2016	44.50M	-56.29%
Dec 31, 2015	101.80M	-40.95%
Dec 31, 2014	172.40M	-52.64%
Dec 31, 2013	364.00M	-24.96%
Dec 31, 2012	485.10M	14.93%
Dec 30, 2011	422.10M	-47.92%
Dec 31, 2010	810.50M	58.46%
Dec 31, 2009	511.50M	266.14%
Dec 31, 2008	139.70M	-45.71%
Dec 31, 2007	257.30M	2,552.58%
Dec 29, 2006	9.70M	-21.77%
Dec 30, 2005	12.40M	1,671.43%
Dec 31, 2004	700.00K	-41.67%
Dec 31, 2003	1.20M	300.00%
Dec 31, 2002	300.00K	-57.14%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Equillium	182.72M
Milestone Pharmaceuticals	181.63M
MediWound	181.22M
Precision BioSciences	180.36M
TuHURA Biosciences	174.49M
Innate Pharma	173.31M
OnKure Therapeutics	172.69M
Turn Therapeutics	171.92M

Market Cap Rankings